Literature DB >> 15898937

In vitro evidence that the biological effects of platelet-rich plasma on periodontal ligament cells is not mediated solely by constituent transforming-growth factor-beta or platelet-derived growth factor.

Tomoyuki Kawase1, Kazuhiro Okuda, Yoshinori Saito, Hiromasa Yoshie.   

Abstract

BACKGROUND: The biological actions of platelet-rich plasma (PRP) are thought to be mediated primarily by constituent transforming-growth factor-beta1 (TGF-beta1) and platelet-derived growth factor-AB (PDGF-AB). However, we previously demonstrated that type I collagen expression in periodontal ligament (PDL) cells is acutely stimulated through fibrin clot formation produced by the fibrinogen within PRP, rather than by the known growth factors. To investigate the possible involvement of other unidentified components in PRP action, we have now compared the effects of PRP with those of known recombinant growth factors on cell proliferation, alkaline phosphatase (ALP) activity, and collagen synthesis in human PDL cell cultures.
METHODS: PRP was prepared by an established two-step centrifugation protocol using blood obtained from adult human volunteers. Cells cultured in serum-reduced medium on native or collagen-coated plates were treated with PRP, TGF-beta1, or PDGF-AB. Cellular DNA synthesis was evaluated by bromodeoxyuridine incorporation. ALP activity was assessed using p-nitrophenylphosphate with formalin-fixed cells, and cellular DNA content was subsequently quantified using bis-benzimide. Collagen synthesis was evaluated using a specific dye-based assay kit.
RESULTS: 1) As did both TGF-beta1 and PDGF-AB, PRP stimulated cell proliferation. 2) However, only the initial mitogenic action of PRP was attenuated in collagen-coated plates. 3) PRP, but neither growth factor, immediately induced fibrin clot formation and subsequently stimulated cellular adhesion and collagen synthesis. 4) These effects were significantly augmented on collagen-coated plates. 5) PRP enhanced ALP activity, but neither TGF-beta1 nor PDGF-AB replicated this effect.
CONCLUSIONS: When evaluated versus the concentrations of growth factors known to be contained by our PRP preparations, these data support the concept that PRP-constituent TGF-beta1 acts as a significant growth factor on PDL cells. However, our findings also strongly suggest that the PRP-induced increase in ALP activity is mediated by an as-yet-unidentified component(s). In conjunction with previously demonstrated fibrinogen-mediated actions, our data provide evidence that PRP produces a number of potent effects on PDL cells that does not solely reflect simple combination of its major known growth factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15898937     DOI: 10.1902/jop.2005.76.5.760

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  21 in total

1.  Platelet-rich plasma provides nucleus for mineralization in cultures of partially differentiated periodontal ligament cells.

Authors:  Tomoyuki Kawase; Kazuhiro Okuda; Yoshinori Saito; Norio Amizuka; Hironobu Suzuki; Hiromasa Yoshie
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

2.  Comparison of platelet pellet with or without guided tissue regeneration in the treatment of class II furcation defects in dogs.

Authors:  Gonca Cayir Keles; Burcu Ozkan Cetinkaya; Sancar Baris; Davut Albayrak; Selen Burcak Simsek
Journal:  Clin Oral Investig       Date:  2008-12-20       Impact factor: 3.573

3.  Platelets, but not erythrocytes, significantly affect cytokine release and scaffold contraction in a provisional scaffold model.

Authors:  May Jacobson; Duretti Fufa; Eduardo L Abreu; Sherwin Kevy; Martha M Murray
Journal:  Wound Repair Regen       Date:  2008 May-Jun       Impact factor: 3.617

4.  The effects of platelet-rich plasma derived from human umbilical cord blood on the osteogenic differentiation of human dental stem cells.

Authors:  Jung-Yeon Lee; Hyun Nam; Yoon-Jeong Park; Seung-Jin Lee; Chong-Pyoung Chung; Soo-Boo Han; Gene Lee
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-17       Impact factor: 2.416

5.  Comparison of mesenchymal stem cells and autogenous cortical bone graft in the treatment of class II furcation defects in dogs.

Authors:  S Burcak Simsek; Gonca Cayir Keles; Sancar Baris; Burcu Ozkan Cetinkaya
Journal:  Clin Oral Investig       Date:  2010-11-18       Impact factor: 3.573

6.  Effects of platelet-poor plasma, platelet-rich plasma, and platelet-rich fibrin on healing of extraction sockets with buccal dehiscence in dogs.

Authors:  Ichiro Hatakeyama; Eriko Marukawa; Yukinobu Takahashi; Ken Omura
Journal:  Tissue Eng Part A       Date:  2013-11-27       Impact factor: 3.845

7.  The effect of different platelet-rich plasma concentrations on proliferation and differentiation of human periodontal ligament cells in vitro.

Authors:  J Han; H X Meng; J M Tang; S L Li; Y Tang; Z B Chen
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

8.  Platelet-Rich Blood Derivatives for Stem Cell-Based Tissue Engineering and Regeneration.

Authors:  Elham Masoudi; João Ribas; Gaurav Kaushik; Jeroen Leijten; Ali Khademhosseini
Journal:  Curr Stem Cell Rep       Date:  2016-02-13

9.  Treatment with a growth factor-protein mixture inhibits formation of mineralized nodules in osteogenic cell cultures grown on titanium.

Authors:  Marcos Andrade de Oliva; William Marcatti Amarú Maximiano; Larissa Moreira Spínola de Castro; Paulo Eliandro da Silva; Roger Rodrigo Fernandes; Pietro Ciancaglini; Márcio Mateus Beloti; Antonio Nanci; Adalberto Luiz Rosa; Paulo Tambasco de Oliveira
Journal:  J Histochem Cytochem       Date:  2008-11-24       Impact factor: 2.479

10.  Platelet-rich plasma in the treatment of Class II furcation defects: a histometrical study in dogs.

Authors:  Fabrícia Ferreira Suaid; Marcelo Diniz Carvalho; Gláucia Maria Bovi Ambrosano; Francisco Humberto Nociti; Marcio Zaffalon Casati; Enilson Antônio Sallum
Journal:  J Appl Oral Sci       Date:  2012 Mar-Apr       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.